New miRNA test could spot hidden virus after transplant
NCT ID NCT07210242
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 29 times
Summary
This study will test a new blood test that looks for tiny molecules called miRNAs to detect HCMV infection earlier in people who have received a stem cell transplant. The standard DNA test can miss early signs, so researchers hope this new method will give doctors a head start. About 300 patients in China will participate, and their blood will be checked before and after transplant to compare the two tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PSTM-qPCR miRNA detection technology
What this could lead to
If successful, this could provide a faster, more accurate way to detect HCMV infection after stem cell transplant, allowing earlier treatment and potentially reducing complications.
What could go wrong
This is an observational study, not a treatment trial. The new test may not prove more effective than current DNA testing, and results may not apply outside the study centers in China.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.